Metal−Organic Frameworks Nucleated by Silk Fibroin and Modified with Tumor‐Targeting Peptides for Targeted Multimodal Cancer Therapy
Advanced Science · 2023-10 · 10 (28)
DOI: 10.1002/advs.202302700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.08.2023. Verfasst von Yuping Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Bioresource Research, College of Animal Science, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang, 310058, P. R. Chi…. Hauptthemen laut MEDLINE: Fibroins, Metal-Organic Frameworks, Peptides, Breast Neoplasms. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Science and Technology Plan, National Natural Science Foundation of China, Provincial Key Laboratory Construction Plans.
Abstract (Originalsprache)
Multimodal therapy requires effective drug carriers that can deliver multiple drugs to specific locations in a controlled manner. Here, the study presents a novel nanoplatform constructed using zeolitic imidazolate framework‐8 ( Z IF‐8), a nanoscale metal‐organic framework nucleated under the mediation of silk fibroin ( S F). The nanoplatform is modified with the newly discovered MCF‐7 breast tumor‐targeting peptide, AREYGTRFSLIGGYR ( AR peptide). Indocyanine green ( I CG) and doxorubicin ( D OX) are loaded onto the nanoplatform with high drug encapsulation efficiency (>95%). ICG enables the resultant nanoparticles (NPs), called AR‐ZS/ID‐P, to release reactive oxygen species for photodynamic therapy ( P DT) and heat for photothermal therapy ( P TT) under near‐infrared (NIR) irradiation, promoting NIR fluorescence and thermal imaging to guide DOX‐induced chemotherapy. Additionally, the controlled release of both ICG and DOX at acidic tumor conditions due to the dissolution of ZIF‐8 provides a drug‐targeting mechanism in addition to the AR peptide. When intravenously injected, AR‐ZS/ID‐P NPs specifically target breast tumors and exhibit higher anticancer efficacy than other groups through ICG‐enabled PDT and PTT and DOX‐derived chemotherapy, without inducing side effects. The results demonstrate that AR‐ZS/ID‐P NPs are a promising multimodal theranostic nanoplatform with maximal therapeutic efficacy and minimal side effects for targeted and controllable drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Applied Bioresource Research, College of Animal Science, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang, 310058, P. R. China.
- Jiangxi Cash Crops Institute, Nanchang, Jiangxi, 330202, P. R. China.
- Department of Neurosurgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 East Qingchun Road, Hangzhou, Zhejiang, 310016, P. R. China.
- Department of Biomedical Engineering, The Chinese University of Hong Kong, Sha Tin, Hong Kong SAR, P. R. China.
- School of Materials Science & Engineering, Zhejiang University, Hangzhou, 310027, China.
ORCID-Profile: Chuanbin Mao
Förderung
- Zhejiang Provincial Science and Technology Plan
- National Natural Science Foundation of China
- Provincial Key Laboratory Construction Plans
- State of Sericulture Industry Technology System
- Plan of National and Zhejiang Provincial Youth Science and Technology Innovation leader
- Technology Innovation Guidance Project of Jiangxi Province
- National Postdoctoral Science Foundation of China
- eZhejiang Provincial Science and Technology Plans
Zitieren
APA
Chen, Y., Lyu, R., Wang, J., Cheng, Q., Yu, Y., Yang, S., Mao, C., & Yang, M. (2023). Metal−Organic Frameworks Nucleated by Silk Fibroin and Modified with Tumor‐Targeting Peptides for Targeted Multimodal Cancer Therapy. Advanced Science, 10(28). https://doi.org/10.1002/advs.202302700
Vancouver
Chen Y, Lyu R, Wang J, Cheng Q, Yu Y, Yang S, et al. Metal−Organic Frameworks Nucleated by Silk Fibroin and Modified with Tumor‐Targeting Peptides for Targeted Multimodal Cancer Therapy. Advanced Science. 2023;10(28). doi:10.1002/advs.202302700
BibTeX
@article{Chen2023,
author = {Chen, Yuping and Lyu, Ruyin and Wang, Jie and Cheng, Qichao and Yu, Yanfang and Yang, Shuxu and Mao, Chuanbin and Yang, Mingying},
title = {Metal−Organic Frameworks Nucleated by Silk Fibroin and Modified with Tumor‐Targeting Peptides for Targeted Multimodal Cancer Therapy},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {28},
doi = {10.1002/advs.202302700}
}
EUVIMED